Similarly, in acquired cetuximab-resistant colon cancer cells, overexpression of TGF-α induced the EGFR-MET interaction with subsequent MET phosphorylation, which contributed to cetuximab resistance [26]. Here, MET is linked to malignant colon neoplasm.